-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Mammary Neoplasms, Experimental are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Mammary Neoplasms, Experimental.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.
Matsui Y, Halter SA, Holt JT, Hogan BL, Coffey RJ
(1990) Cell 61: 1147-55 - Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis.
McCaffrey LM, Montalbano J, Mihai C, Macara IG
(2012) Cancer Cell 22: 601-14 - Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.
Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schübeler D, van Nimwegen E, Christofori G
(2013) Cancer Cell 23: 768-83 - Relationship of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats.
Matusik RJ, Hilf R
(1976) J Natl Cancer Inst 56: 659-61 - Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.
Stanford JC, Young C, Hicks D, Owens P, Williams A, Vaught DB, Morrison MM, Lim J, Williams M, Brantley-Sieders DM, Balko JM, Tonetti D, Earp HS, Cook RS
(2014) J Clin Invest 124: 4737-52 - MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis.
Cook RS, Jacobsen KM, Wofford AM, DeRyckere D, Stanford J, Prieto AL, Redente E, Sandahl M, Hunter DM, Strunk KE, Graham DK, Earp HS
(2013) J Clin Invest 123: 3231-42 - The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J
(2008) J Clin Invest 118: 64-78 - Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.
Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL
(2007) J Clin Invest 117: 1305-13 - The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.
Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O'Rear LD, Nashabi A, Li Z, Dupont WD, Zijlstra A, Zutter MM
(2011) J Clin Invest 121: 226-37 - Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.
Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ
(2000) Genes Dev 14: 1448-59 - TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.
Novitskiy SV, Pickup MW, Gorska AE, Owens P, Chytil A, Aakre M, Wu H, Shyr Y, Moses HL
(2011) Cancer Discov 1: 430-41 - DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer.
Luo N, Nixon MJ, Gonzalez-Ericsson PI, Sanchez V, Opalenik SR, Li H, Zahnow CA, Nickels ML, Liu F, Tantawy MN, Sanders ME, Manning HC, Balko JM
(2018) Nat Commun 9: 248 - Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
Pierce DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ, Moses HL
(1995) Proc Natl Acad Sci U S A 92: 4254-8 - Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL
(2000) Proc Natl Acad Sci U S A 97: 9609-14 - Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells.
Zutter MM, Santoro SA, Staatz WD, Tsung YL
(1995) Proc Natl Acad Sci U S A 92: 7411-5 - Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies.
Hanker AB, Pfefferle AD, Balko JM, Kuba MG, Young CD, Sánchez V, Sutton CR, Cheng H, Perou CM, Zhao JJ, Cook RS, Arteaga CL
(2013) Proc Natl Acad Sci U S A 110: 14372-7 - Matrix stiffening promotes a tumor vasculature phenotype.
Bordeleau F, Mason BN, Lollis EM, Mazzola M, Zanotelli MR, Somasegar S, Califano JP, Montague C, LaValley DJ, Huynh J, Mencia-Trinchant N, Negrón Abril YL, Hassane DC, Bonassar LJ, Butcher JT, Weiss RS, Reinhart-King CA
(2017) Proc Natl Acad Sci U S A 114: 492-497 - Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors.
Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA, Arteaga CL
(2004) Cancer Res 64: 9002-11 - Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.
Coffey RJ, Meise KS, Matsui Y, Hogan BL, Dempsey PJ, Halter SA
(1994) Cancer Res 54: 1678-83 - HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta.
Wang SE, Shin I, Wu FY, Friedman DB, Arteaga CL
(2006) Cancer Res 66: 9591-600 - ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.
Cook RS, Garrett JT, Sánchez V, Stanford JC, Young C, Chakrabarty A, Rinehart C, Zhang Y, Wu Y, Greenberger L, Horak ID, Arteaga CL
(2011) Cancer Res 71: 3941-51 - Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.
Yan HH, Pickup M, Pang Y, Gorska AE, Li Z, Chytil A, Geng Y, Gray JW, Moses HL, Yang L
(2010) Cancer Res 70: 6139-49 - Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L
(2007) Cancer Res 67: 75-84 - Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL
(2008) Cancer Res 68: 1809-19 - Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.
Pulaski BA, Ostrand-Rosenberg S
(1998) Cancer Res 58: 1486-93 - The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis.
Xue C, Plieth D, Venkov C, Xu C, Neilson EG
(2003) Cancer Res 63: 3386-94 - Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells.
Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF
(1992) Cancer Res 52: 2489-96 - Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics.
Reyzer ML, Caldwell RL, Dugger TC, Forbes JT, Ritter CA, Guix M, Arteaga CL, Caprioli RM
(2004) Cancer Res 64: 9093-100 - Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL
(2005) Cancer Res 65: 2296-302 - Membrane glycoprotein differences between normal lactating mammary tissue and the R3230 AC mammary tumor.
Shin BC, Ebner KE, Hudson BG, Carraway KL
(1975) Cancer Res 35: 1135-40 - Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.
Pulaski BA, Terman DS, Khan S, Muller E, Ostrand-Rosenberg S
(2000) Cancer Res 60: 2710-5 - Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
Min Y, Ren X, Vaught DB, Chen J, Donnelly E, Lynch CC, Lin PC
(2010) Cancer Res 70: 2819-28 - Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.
Young CD, Pfefferle AD, Owens P, Kuba MG, Rexer BN, Balko JM, Sánchez V, Cheng H, Perou CM, Zhao JJ, Cook RS, Arteaga CL
(2013) Cancer Res 73: 4075-85 - IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways.
Venmar KT, Carter KJ, Hwang DG, Dozier EA, Fingleton B
(2014) Cancer Res 74: 4329-40 - Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.
Martin MD, Carter KJ, Jean-Philippe SR, Chang M, Mobashery S, Thiolloy S, Lynch CC, Matrisian LM, Fingleton B
(2008) Cancer Res 68: 6251-9 - Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.
Criswell TL, Dumont N, Barnett JV, Arteaga CL
(2008) Cancer Res 68: 7304-12 - Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.
Brantley-Sieders DM, Dunaway CM, Rao M, Short S, Hwang Y, Gao Y, Li D, Jiang A, Shyr Y, Wu JY, Chen J
(2011) Cancer Res 71: 976-87 - Complex N-glycan and metabolic control in tumor cells.
Mendelsohn R, Cheung P, Berger L, Partridge E, Lau K, Datti A, Pawling J, Dennis JW
(2007) Cancer Res 67: 9771-80 - Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
Pickup MW, Laklai H, Acerbi I, Owens P, Gorska AE, Chytil A, Aakre M, Weaver VM, Moses HL
(2013) Cancer Res 73: 5336-46 - Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N, Chytil A, Shyr Y, Joly A, Moses HL
(2007) Cancer Res 67: 4869-77
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
